Schizophrenia, "just the facts" 4. Clinical features and conceptualization
- PMID:19328655
- DOI: 10.1016/j.schres.2009.03.005
Schizophrenia, "just the facts" 4. Clinical features and conceptualization
Abstract
Although dementia praecox or schizophrenia has been considered a unique disease entity for the past century, its definitions and boundaries have continued to vary over this period. At any given time, the changing concept of schizophrenia has been influenced by available diagnostic tools and treatments, related conditions from which it most needs to be distinguished, extant knowledge and scientific paradigms. There is significant heterogeneity in the etiopathology, symptomatology, and course of schizophrenia. It is characterized by an admixture of positive, negative, cognitive, mood, and motor symptoms whose severity varies across patients and through the course of the illness. Positive symptoms usually first begin in adolescence or early adulthood, but are often preceded by varying degrees of negative and cognitive symptomatology. Schizophrenia tends to be a chronic and relapsing disorder with generally incomplete remissions, variable degrees of functional impairment and social disability, frequent comorbid substance abuse, and decreased longevity. Although schizophrenia may not represent a single disease with a unitary etiology or pathogenetic process, alternative approaches have thus far been unsuccessful in better defining this syndrome or its component entities. The symptomatologic, course, and etio-pathological heterogeneity can usefully be addressed by a dimensional approach to psychopathology, a clinical staging approach to illness course, and by elucidating endophenotypes and markers of illness progression, respectively. This will allow an approach to the deconstruction of schizophrenia into its multiple component parts and strategies to reconfigure these components in a more meaningful manner. Possible implications for DSM-V and ICD-11 definitions of schizophrenia are discussed.
Comment in
- Newer conceptualizations of schizophrenia demand a name change.Levin TT.Levin TT.Schizophr Res. 2009 Dec;115(2-3):374. doi: 10.1016/j.schres.2009.09.013. Epub 2009 Oct 2.Schizophr Res. 2009.PMID:19800202No abstract available.
- The facts of schizophrenia: a personal commentary.Carpenter WT.Carpenter WT.Schizophr Res. 2011 May;128(1-3):3-4. doi: 10.1016/j.schres.2011.03.002. Epub 2011 Apr 1.Schizophr Res. 2011.PMID:21458240No abstract available.
Similar articles
- Nosological status and definition of schizophrenia: Some considerations for DSM-V and ICD-11.Tandon R, Maj M.Tandon R, et al.Asian J Psychiatr. 2008 Dec;1(2):22-7. doi: 10.1016/j.ajp.2008.10.002. Epub 2008 Nov 25.Asian J Psychiatr. 2008.PMID:23050991
- Beyond the facts in schizophrenia: closing the gaps in diagnosis, pathophysiology, and treatment.Nasrallah H, Tandon R, Keshavan M.Nasrallah H, et al.Epidemiol Psychiatr Sci. 2011 Dec;20(4):317-27. doi: 10.1017/s204579601100062x.Epidemiol Psychiatr Sci. 2011.PMID:22201209Review.
- [Psychopathology of schizophrenia and brain imaging].Gross G, Huber G.Gross G, et al.Fortschr Neurol Psychiatr. 2008 May;76 Suppl 1:S49-56. doi: 10.1055/s-2008-1038152.Fortschr Neurol Psychiatr. 2008.PMID:18461545Review.German.
- [Diagnosing schizophrenia: from Bleuler to DSM-V].Réthelyi J.Réthelyi J.Neuropsychopharmacol Hung. 2011 Dec;13(4):193-203.Neuropsychopharmacol Hung. 2011.PMID:22184187Review.Hungarian.
- [A hundred years of schizophrenia: from Bleuler to DSM-V].Blom JD.Blom JD.Tijdschr Psychiatr. 2007;49(12):887-95.Tijdschr Psychiatr. 2007.PMID:18175290Dutch.
Cited by
- Polygenic Risk Scores for Subtyping of Schizophrenia.Chen J, Mize T, Wu JS, Hong E, Nimgaonkar V, Kendler KS, Allen D, Oh E, Netski A, Chen X.Chen J, et al.Schizophr Res Treatment. 2020 Jul 23;2020:1638403. doi: 10.1155/2020/1638403. eCollection 2020.Schizophr Res Treatment. 2020.PMID:32774919Free PMC article.
- Brain Structural Changes in Schizophrenia Patients Compared to the Control: An MRI-based Cavalieri's Method.Heidari Z, Mahmoudzadeh-Sagheb H, Shakiba M, Gorgich EAC.Heidari Z, et al.Basic Clin Neurosci. 2023 May-Jun;14(3):355-363. doi: 10.32598/bcn.2021.3481.1. Epub 2023 May 1.Basic Clin Neurosci. 2023.PMID:38077177Free PMC article.
- Attenuated psychosis and the schizophrenia prodrome: current status of risk identification and psychosis prevention.Tandon N, Shah J, Keshavan MS, Tandon R.Tandon N, et al.Neuropsychiatry (London). 2012;2(4):345-353. doi: 10.2217/npy.12.36.Neuropsychiatry (London). 2012.PMID:23125875Free PMC article.
- Conceptualizing psychotic disorders: don't throw the baby out with the bathwater.Tandon R.Tandon R.World Psychiatry. 2016 Jun;15(2):133-4. doi: 10.1002/wps.20338.World Psychiatry. 2016.PMID:27265703Free PMC article.No abstract available.
- Nicotine's Effects on Schizophrenia-like Symptoms in a Mice Model: Time Matters.Dutra-Tavares AC, Couto LA, Souza TP, Bandeira-Martins A, Silva JO, Filgueiras CC, Ribeiro-Carvalho A, Manhães AC, Abreu-Villaça Y.Dutra-Tavares AC, et al.Brain Sci. 2024 Aug 25;14(9):855. doi: 10.3390/brainsci14090855.Brain Sci. 2024.PMID:39335351Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous